Press Releases

  • Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics

    Leading computational physics-based platform for design and optimization of small molecules bolsters Roivant’s drug discovery capabilities Silicon Therapeutics drug discovery executives Dr. Woody Sherman, Dr. Huafeng Xu, and Dr. Chris Winter to join Roivant leadership; Drs. Sherman and Xu are industry pioneers in computationally powered drug discovery Physics-based approaches at Silicon Therapeutics to be integrated